Likewise in Continence Care, where Coloplast enjoys a better share in the U.S. (around 30%), but still less than it enjoys overall (40%-plus). Luja, a new intermittent catheter designed to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback